EIF4A3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.935200E-01
Normal-vs-Stage2
6.639200E-01
Normal-vs-Stage3
9.585600E-01
Normal-vs-Stage4
2.342200E-01
Stage1-vs-Stage2
2.254400E-01
Stage1-vs-Stage3
6.171800E-01
Stage1-vs-Stage4
1.020180E-01
Stage2-vs-Stage3
6.760200E-01
Stage2-vs-Stage4
8.252800E-01
Stage3-vs-Stage4
6.281600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.228600E-01
Normal-vs-AfricanAmerican
3.528400E-01
Normal-vs-Asian
9.770000E-01
Caucasian-vs-AfricanAmerican
6.018000E-01
Caucasian-vs-Asian
5.253600E-01
AfricanAmerican-vs-Asian
2.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.496000E-01
Normal-vs-Female
6.408200E-01
Male-vs-Female
7.014000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.228600E-01
Normal-vs-Age(41-60Yrs)
4.105600E-01
Normal-vs-Age(61-80Yrs)
9.010800E-01
Normal-vs-Age(81-100Yrs)
7.318400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.488000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.800400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.453000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.921600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.802400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.954800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.692400E-01
Normal-vs-Daily Drinker
7.692800E-01
Normal-vs-Weekly Drinker
4.679600E-01
Normal-vs-Occasional Drinker
5.825400E-01
Normal-vs-Social Drinker
6.261000E-01
Non Drinker-vs-Daily Drinker
3.413000E-01
Non Drinker-vs-Weekly Drinker
2.886200E-01
Non Drinker-vs-Occasional Drinker
1.331810E-01
Non Drinker-vs-Social Drinker
2.643400E-01
Daily Drinker-vs-Weekly Drinker
7.257000E-01
Daily Drinker-vs-Occasional Drinker
5.165800E-01
Daily Drinker-vs-Social Drinker
8.240400E-01
Weekly Drinker-vs-Occasional Drinker
8.716000E-01
Weekly Drinker-vs-Social Drinker
8.659200E-01
Occasional Drinker-vs-Social Drinker
6.702400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.610200E-01
Normal-vs-Grade 2
8.181200E-01
Normal-vs-Grade 3
8.339600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.023960E-01
Grade 1-vs-Grade 3
4.351900E-02
Grade 1-vs-Grade 4
7.610200E-01
Grade 2-vs-Grade 3
5.974000E-01
Grade 2-vs-Grade 4
8.181200E-01
Grade 3-vs-Grade 4
8.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.797800E-01
Normal-vs-NonDiabetic
6.938000E-01
Diabetic-vs-NonDiabetic
2.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.704000E-01
Normal-vs-NoPancreatitis
7.557800E-01
Pancreatitis-vs-NoPancreatitis
9.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.058600E-01
Normal-vs-N1
6.358200E-01
N0-vs-N1
2.067400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.148810E-01
Normal-vs-TP53-NonMutant
7.442200E-01
TP53-Mutant-vs-TP53-NonMutant
2.515000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
